STAAR Surgical(NASDAQ) STAA

STAAR Surgical Company is a leader in the ophthalmic products industry, focusing on the design, development, and sale of Implantable Collamer Lenses (ICLs). These lenses are used for minimally invasive eye surgeries that correct refractive conditions like myopia and astigmatism. Founded in 1982, the company has dedicated its efforts solely to ophthalmic products, distinguishing itself with proprietary lens material and innovative surgical solutions.

Products and Services

Implantable Collamer Lenses (ICLs) for refractive surgery

EVO Visian ICL for myopia and astigmatism correction

EVO Viva for presbyopia with an extended depth of focus optic

Visian ICL for hyperopia correction

Accessory delivery systems for lens implantation

What Makes STAAR Surgical Company Special

STAAR Surgical Company sets itself apart with its proprietary Collamer lens material, which offers superior biocompatibility, comfort, and flexibility compared to traditional silicone or acrylic lenses. Its innovative EVO ICL eliminates the need for pre-operative iridotomies, enhancing patient experience and surgical efficiency. This focus on cutting-edge lens technology positions STAAR as a niche leader in the permanent vision correction market.

Five Things You Need to Know

STAAR generates nearly all its revenue from its ICL products.

Operations are global, with 94% of sales coming from outside the U.S.

The company is expanding into new geographic markets to drive growth.

Proprietary Collamer material is exclusive to STAAR's lens offerings.

STAAR is investing in R&D for new lens technologies and market expansion.